• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts & Webinars
    • Podcasts
    • Webinars
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
  • Coronavirus: Live updates

Capella Inc.

FDA approves STJ’s MRI-safe SCS device | Regulatory news for the week of May 4, 2015

May 5, 2015 By MassDevice Leave a Comment

FDA approves MRI-safe SCS device from St. Jude Medical

April 30, 2015 by Brad Perriello

Filed Under: Food & Drug Administration (FDA), News Well, Regulatory/Compliance Tagged With: C.R. Bard, Capella Inc., CryoLife, Federal Trade Commission (FTC), Stentys, stjudemedical, Tornier Inc., wrightmedical

Surprise CE Mark for Stentys Xposition S stent

April 30, 2015 By Mark Hollmer Leave a Comment

Surprise CE Mark for Stentys Xposition S stent

Stentys this week said it won a CE Mark ahead of schedule for its latest self-apposing coronary stent, a product that will be used with delivery system technology it acquired last June.

Filed Under: News Well, Regulatory/Compliance, Stents Tagged With: Capella Inc., CE Mark, Stentys

St. Jude Medical wins CE Mark, launches Enlightn renal denervation system | MassDevice.com On Call

May 15, 2012 By MassDevice staff Leave a Comment

MassDevice On Call

MASSDEVICE ON CALL —St. Jude Medical (NYSE:STJ) landed CE Mark approval and announced commercial launch for its Enlightn renal denervation system as a treatment for hypertension.

Filed Under: News Well Tagged With: Abbott, Boston Scientific, Capella Inc., Clinical Trials, InfraReDx Inc., neovasc, On Call, Renal, Stentys, stjudemedical, Svelte Medical Systems Inc., Volcano Corp.

Medtronic regulatory chief Susan Alpert to step down

April 8, 2011 By MassDevice staff Leave a Comment

Susan Alpert

Medtronic Inc.’s (NYSE:MDT) chief regulatory affairs officer Susan Alpert will join her boss, William Hawkins, on Retirement Row this year, according to company officials.

Alpert, who has held the senior vice president and chief regulatory officer positions at Medtronic since 2005, had a similar role at C.R. Bard (NYSE:BCR) before joining MDT and is also a former director of the FDA’s Office of Device Evaluation .

Filed Under: News Well Tagged With: Capella Inc., CareFusion Corp., GenMark Diagnostics Inc., HemaCare Corp., OraSure Technologies Inc., Personnel Moves

Medtronic “internal cast” effective on cancer patients’ spinal fractures | Research roundup

February 18, 2011 By MassDevice staff Leave a Comment

Clinical trials roundup

Here’s a roundup of recent clinical trial and scientific study news:

Filed Under: Business/Financial News, News Well Tagged With: Capella Inc., Clinical Trials

Cappella closes $14.3 million round | Funding roundup

February 17, 2011 By MassDevice staff Leave a Comment

M and A Roundup

Here’s a roundup of the latest dealflow and investment news:

Filed Under: Business/Financial News, News Well Tagged With: Angiotech, Capella Inc.

pSivida touts latest diabetic macular edema study results | Research roundup

February 5, 2011 By MassDevice staff Leave a Comment

Clinical trials roundup

Here’s a roundup of recent clinical trial and scientific study news:

Filed Under: Business/Financial News, News Well Tagged With: Capella Inc., Clinical Trials, Metamark Genetics Inc., pSivida Corp.

Delcath CEO Hobbs takes top spot on Capella’s board

June 18, 2010 By MassDevice staff Leave a Comment

Capella logo

Eamonn Hobbs took over as board chairman for Irish stent-maker Capella Inc.

Hobbs is CEO of Delcath Systems Inc. (NSDQ:DCTH), a New York-based manufacturer of arterially administered cancer treatments, and was CEO and co-founder of AngioDynamics (NSDQ:ANGO). Hobbs fills the position of former Capella chairman Dr. Wolfgang Oster, a managing partner at PolyTechnos Venture-Partners GmbH.

Filed Under: Business/Financial News, News Well, Stents Tagged With: Capella Inc.

Primary Sidebar

DeviceTalks Weekly

May 20, 2022
DeviceTalks Boston Post-Game – Editors’ Top Moments, Insulet’s Eric Benjamin on future of Omnipod 5
See More >

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World

Device Talks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our Device Talks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us
Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS